The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Extended lab space for product development, customer demos, and training
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
Bourgoin early development hub broadens offerings for oral solid dose formulations
Investment further strengthens Merck's "Big 3," the key drivers for increasing Group sales to approximately € 25 billion by 2025
The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
Subscribe To Our Newsletter & Stay Updated
